Abstrakti
Background: Asthma program in Finland decreased asthma-related mortality and expenses of care on national level, but there is lack of data on adherence to treatment guidelines and disease control on individual level. We aimed to assess adherence to guidelines and disease control among Finnish adult asthmatics. Methods: Questionnaires were sent in Finland to 2000 randomly selected recipients aged 18–80 years, who had bought medication for obstructive airways disease during the previous 12 months. The questionnaire included questions on asthma medication, exacerbations, self-management and follow-up. Asthma symptom control was assessed by the Asthma Control Test (ACT). Results: A high proportion (82.4%) of the 541 responders with physician-diagnosed asthma reported regular use of asthma medication and 97.1% of them used inhaled corticosteroids. Almost all (97.0%) of the asthmatics were taught how to use their inhaler and 78.4% had an asthma self-management plan, but only 35.7% reported regular annual follow-up visits. According to symptoms, 60.0% had their asthma well-controlled (ACT score ≥20). On the other hand, 29.2% had a course of oral corticosteroid and 21.8% had an asthma-related unscheduled health care visit during the previous year, but only 2.6% reported a hospitalization. Asthma control was better in those not using regular asthma medication. Conclusions: The guidelines are well adopted in Finnish adult asthma care except for regular follow-up visits. Majority of patients had good symptom control and hospitalizations were rare. Better asthma control among those not using regular asthma medication implies they are not undertreated but have a mild disease.
Alkuperäiskieli | Englanti |
---|---|
Artikkeli | 2149918 |
Julkaisu | European Clinical Respiratory Journal |
Vuosikerta | 10 |
Numero | 1 |
Varhainen verkossa julkaisun päivämäärä | 26 marrask. 2022 |
DOI - pysyväislinkit | |
Tila | Julkaistu - 2023 |
OKM-julkaisutyyppi | A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä |
Rahoitus
This study was supported by grants from Tampere Tuberculosis Foundation, Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital, the Research Foundation of the Pulmonary Diseases, Allergy Research Foundation, and the Foundation of the Finnish Anti-Tuberculosis Association.
Julkaisufoorumi-taso
- Jufo-taso 1
!!ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine